GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Price-to-Owner-Earnings

PharmaTher Holdings (XCNQ:PHRM) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Price-to-Owner-Earnings?

As of today (2024-06-05), PharmaTher Holdings's share price is C$0.22. PharmaTher Holdings does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for PharmaTher Holdings's Price-to-Owner-Earnings or its related term are showing as below:


XCNQ:PHRM's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.035
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), PharmaTher Holdings's share price is C$0.22. PharmaTher Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.05. Therefore, PharmaTher Holdings's PE Ratio for today is At Loss.

As of today (2024-06-05), PharmaTher Holdings's share price is C$0.22. PharmaTher Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.05. Therefore, PharmaTher Holdings's PE Ratio without NRI for today is At Loss.

During the past 3 years, PharmaTher Holdings's highest PE Ratio without NRI was 16.67. The lowest was 0.00. And the median was 0.00.


PharmaTher Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for PharmaTher Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Price-to-Owner-Earnings Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Price-to-Owner-Earnings
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PharmaTher Holdings's Price-to-Owner-Earnings

For the Biotechnology subindustry, PharmaTher Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Price-to-Owner-Earnings falls into.



PharmaTher Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PharmaTher Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.22/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PharmaTher Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines